🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 17 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
24/02/2010 5,80 6,00 5,70 5,70 -1,72% 5,17% 2.910
23/02/2010 6,00 6,10 5,80 5,80 -3,33% 5,00% 2.140
22/02/2010 5,90 6,10 5,80 6,00 +1,69% 5,08% 14.010
19/02/2010 6,20 6,20 5,90 5,90 -0,84% 4,84% 3.520
18/02/2010 5,80 6,00 5,80 5,95 +2,59% 3,45% 4.920
17/02/2010 6,20 6,28 5,80 5,80 -1,69% 7,74% 7.740
16/02/2010 5,80 6,30 5,70 5,90 +1,72% 10,34% 10.160
12/02/2010 5,70 6,00 5,70 5,80 +0,00% 5,26% 10.690
11/02/2010 6,10 6,30 5,80 5,80 -6,45% 8,20% 13.330
10/02/2010 6,20 6,20 6,00 6,20 +0,00% 3,23% 9.400
09/02/2010 6,10 6,39 5,81 6,20 +3,33% 9,51% 11.650
08/02/2010 6,00 6,30 6,00 6,00 +0,00% 5,00% 7.830
05/02/2010 5,70 6,00 5,70 6,00 +0,00% 5,26% 17.080
04/02/2010 6,40 6,40 5,90 6,00 -4,00% 7,81% 15.320
03/02/2010 6,00 6,35 6,00 6,25 +4,17% 5,83% 12.200
02/02/2010 5,70 6,10 5,70 6,00 +5,26% 7,02% 4.840
01/02/2010 6,00 6,00 5,70 5,70 +0,00% 5,00% 8.480
29/01/2010 5,60 5,85 5,60 5,70 +1,97% 4,46% 6.100
28/01/2010 6,00 6,09 5,50 5,59 -3,62% 9,83% 7.800
27/01/2010 6,00 6,20 5,80 5,80 -9,52% 6,67% 35.460
26/01/2010 7,10 7,10 6,41 6,41 -5,74% 9,72% 14.460
25/01/2010 6,40 7,30 6,40 6,80 +3,03% 14,06% 59.530
22/01/2010 6,05 6,80 5,60 6,60 +8,20% 19,83% 44.940
21/01/2010 6,20 6,30 6,10 6,10 -3,17% 3,23% 9.510
20/01/2010 6,50 6,60 6,03 6,30 +5,00% 8,77% 28.960
19/01/2010 6,30 6,30 5,80 6,00 +2,56% 7,94% 13.630
15/01/2010 6,00 6,30 5,85 5,85 -2,50% 7,50% 10.760
14/01/2010 5,84 6,04 5,82 6,00 +5,26% 3,77% 11.020
13/01/2010 5,73 5,90 5,55 5,70 +1,79% 6,11% 13.920
12/01/2010 6,00 6,30 5,60 5,60 -6,67% 11,67% 21.650